Sydney, Australia, September 17th, 2020 - InMode Ltd (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to announce the expansion of the unique Morpheus8 RF Microneedling technology by introducing Morpheus8 Body.
Morpheus8 Body is the first intelligent, programmable, full body fractional technology to deliver clinically proven radiofrequency (RF) energy up to a thermal depth of 8mm (7mm pin depth plus an additional 1mm heat thermal profile) with its 40 gold coated pins.
As the first and only FDA cleared and TGA listed technology to penetrate subdermal tissue with a thermal profile of 8mm, the new Morpheus8 Body technology is designed to provide physicians with a faster, bigger and better solution to deliver customisable full body fractional treatments. Based on the success of InMode's proprietary technology, the new Morpheus8 extends its line of Subdermal Adipose Remodelling Devices (SARD).
The new Morpheus8 platform is the complete state-of-the-art workstation with dual handpieces and four fractional tips with different microneedle configurations: Prime 12 pin, Resurfacing 24 pin, Morpheus8 24 pin and Body 40 pin. The Morpheus8 platform provides clinics with a standalone solution for fractional RF, ranging from the Morpheus8 Prime for the treatment of delicate areas with high tissue curvature such as the eyes and nasolabial fold, to the Morpheus8 Body for large zones such as the abdomen, thighs and buttocks.
Dennis Cronje, Managing Director of InMode Australia, commented "The addition of Morpheus8 Prime and Body provides a complete fractional RF solution unlike anything available currently. These new treatment modalities can provide a customisable, full body solution for each patient.
True innovation in the industry has become scarce and this is where InMode will continue to thrive. We are excited about the new treatment capabilities for both our physicians and their patients".
Dr. Stephen Mulholland added, "Morpheus8 has become a standard treatment in my clinic. Whether I use it as a stand-alone treatment for tightening and smoothing of the skin or combined with one of my other treatments, it is my go-to treatment for patients looking for significant, but non-surgical, remodelling improvement”.
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted, minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynaecology, dermatology, otolaryngology and ophthalmology.
For more information about InMode, please visit www.inmode.com.au